Biopta is a GLP compliant discovery/preclinical contract research organisation (CRO) specialising in ex vivo human tissue services.
We aim to improve the predictability of drug development by utilising ethically donated fresh human tissues to provide powerful data on human safety and/or efficacy much earlier in the development process.
We believe these early ex vivo human studies, the closest model to human in vivo function, provide invaluable data to accurately identify compounds with the greatest likelihood of clinical success; streamlining preclinical development and reducing the cost and risk of clinical failures.
We deliver a high quality, customer focussed and flexible service to global pharmaceutical and biotechnology companies, providing both validated assays and bespoke research services.
Accelerating Development, Reducing Risk